AC Immune (ACIU) Interest Expenses (2015 - 2026)

AC Immune (ACIU) has 12 years of Interest Expenses data on file, last reported at -$83005.3 in Q1 2026.

• On a quarterly basis, Interest Expenses fell 38.2% year-over-year to -$83005.3 in Q1 2026; TTM through Mar 2026 was $221990.5, a 326.34% increase from a year earlier, with the FY2025 full-year figure at -$230370.5, down 51.74% from the prior year.
• Interest Expenses for Q1 2026 stood at -$83005.3, down from $422895.4 in the prior quarter.
• Over the last five years, Interest Expenses for ACIU reached as high as $738033.6 in Q4 2022 and fell as low as -$166752.5 in Q1 2022.
• Historically, Interest Expenses has averaged $14691.0 across 5 years, with a median of -$41244.6 in 2024.
• Across the five-year window, Interest Expenses sank 479.86% in 2022 and soared 1022.63% in 2025, its largest moves.
• Year by year, Interest Expenses stood at $738033.6 in 2022, then slumped by 103.97% to -$29311.2 in 2023, then surged by 228.52% to $37670.2 in 2024, then surged by 1022.63% to $422895.4 in 2025, then tumbled by 119.63% to -$83005.3 in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were -$83005.3 in Q1 2026, $422895.4 in Q4 2025, and -$57505.0 in Q3 2025.